We recently compiled a list of the 10 Most Promising Growth Stocks According to Hedge Funds. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other Most Promising Growth Stock According to Hedge Funds.

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article

Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 568.82% and currently trading at $884.25. The company has been around since 1876 and the stock didn’t go public until 1952 but in the last 4 years,

Sanibel Captiva Trust Company Inc. lowered its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC.

While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second. Demand for Eli Lilly's Mounjaro and Zepbound remains robust, and sell-side analysts tracking script data shows strong growth for both of these drugs.